Tranylcypromine and Bupropion Interaction

Drug interaction information between Tranylcypromine and Bupropion.

Tranylcypromine and Bupropion have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Tranylcypromine and Bupropion. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Tranylcypromine

Monoamine Oxidase Inhibitor (MAOI)

Drug B

Bupropion

Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)

How They Interact

These two antidepressants can cause a severe reaction when used at the same time. They both change brain chemicals in a way that can lead to dangerously high blood pressure.

FDA Label Information

Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone,...

Frequently Asked Questions

What SPL severity band is on file for Tranylcypromine + Bupropion?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Tranylcypromine has 42 labeled pairs on file vs Bupropion's 35. In the major band specifically: Tranylcypromine has 7 (also Linezolid, Vilazodone, Epinephrine, Norepinephrine); Bupropion has 1.

What mechanism field is on file for Tranylcypromine and Bupropion?

These two antidepressants can cause a severe reaction when used at the same time. They both change brain chemicals in a way that can lead to dangerously high blood pressure.

Tranylcypromine carries more major-labeled pairs than Bupropion

SPL source-record counts only. This page's band is major · classes on file: Tranylcypromine (Monoamine Oxidase Inhibitor (MAOI)); Bupropion (Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)).

Tranylcypromine has 7 major-labeled pairs vs Bupropion's 1.

Tranylcypromine

7 major · 23 moderate · 12 minor · 42 total

Bupropion

1 major · 2 moderate · 32 minor · 35 total

Bupropion has no other major-band peer in this dataset besides Tranylcypromine.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.